UPSC Mains Examiner & Strategic Content Synthesizer. "Health Infrastructure in India — Public vs Private". Governance (Health). A series of articles from May 2026 (simulated dates) covering NFHS-6, Ebola/BSL-4, NHA Estimates, NSS data, and Ayushman Bharat in Bengal. * 3-4 cohesive paragraphs. * Synthesize overarching narrative. * Integrate provided developments. * Structure: Core Challenge $\rightarrow$ Gov/Policy Response $\rightarrow$ Way Forward. * Format: Raw HTML ( for emphasis,
/
for lists,
for paragraphs). * Constraint: No markdown blocks. * *NFHS-6:* Shift from "access-based gaps" (getting people to hospitals) to "quality-of-care gaps" (over-medicalization, unnecessary C-sections in private sector). Double burden of malnutrition. * *Ebola/BSL-4:* Global health security, market failure in NTDs, need for BSL-4 infrastructure, "One Health" framework, strategic health autonomy. * *NHA Estimates:* OOPE dropping (64.2% $\rightarrow$ 43.4%), GHE rising (to 43.7%), but GHE still low at 1.43% of GDP (target 2.5%). Pharmacy costs are the main driver of OOPE. * *NSS Data:* Insurance penetration $\uparrow$ but OOPE still high. Insurance isn't a substitute for public service delivery. Epidemiological transition (Infectious $\rightarrow$ NCDs). * *Ayushman Bharat (Bengal):* Cooperative federalism, portability for migrants, shift from state-specific to national models. * *Paragraph 1: The Core Challenge.* The central conflict is the tension between expanding access (quantitative success) and ensuring quality/equity (qualitative failure). Mention the paradox: high institutional delivery (NFHS-6) vs. commercial exploitation (C-sections). Mention the epidemiological shift (NCDs + infectious diseases) and the persistence of Out-of-Pocket Expenditure (OOPE) despite insurance (NSS data). * *Paragraph 2: Government/Policy Response.* Focus on the shift from high OOPE to state-led financing. Use NHA data (GHE increase). Highlight the scaling of primary care (Ayushman Arogya Mandirs) and the push for Universal Health Coverage (UHC) through Ayushman Bharat. Mention the "portability" aspect (West Bengal case) as a win for migrant health and cooperative federalism. * *Paragraph 3: Specialized Infrastructure & Strategic Autonomy.* Incorporate the BSL-4 and "One Health" perspective. Address the "market failure" of NTDs and the need for indigenous R&D to avoid dependence on global pharmaceutical incentives. This adds a layer of "National Security/Biosecurity" to the "Public vs Private" debate. * *Paragraph 4: The Way Forward (The Synthesis).* Bridge the gap. Need for GHE to reach 2.5% of GDP. Moving from "insurance-led" to "tax-funded" UHC. Regulating the private sector to prevent "over-medicalization." Integration of One Health. * *Refining terminology:* Use terms like "Epidemiological Transition," "Medical Impoverishment," "Cooperative Federalism," and "Strategic Health Autonomy." * *Ensuring HTML compliance:* No ```, use
, ,
.
The landscape of Indian healthcare is currently undergoing a critical transition from "access-based gaps" to "quality-of-care gaps." While structural milestones have been achieved—evidenced by NFHS-6 data showing near-universalization of institutional deliveries (90.6%)—the core challenge has shifted toward the commercial exploitation of healthcare. This is most visible in the "over-medicalization" of childbirth, where urban C-section rates (40%) far exceed WHO norms, signaling a systemic failure in regulating private sector incentives. Furthermore, India faces a complex epidemiological transition, managing a "double burden" of malnutrition (undernutrition and obesity) alongside a rising tide of Non-Communicable Diseases (NCDs), which complicates the delivery of standardized public health services.

In response, the government has pivoted toward a model of increased state-led financing to reduce the burden of Out-of-Pocket Expenditure (OOPE). According to the 10th National Health Accounts, OOPE has dropped from 64.2% to 43.4%, supported by the expansion of Ayushman Arogya Mandirs and free drug programs. The integration of the Ayushman Bharat scheme in states like West Bengal underscores a strategic move toward cooperative federalism and "portability," ensuring that the migrant workforce can access cashless secondary and tertiary care across state borders. However, this insurance-centric approach faces a paradox: while insurance penetration is rising, NSS data suggests it is not a sufficient substitute for robust public service delivery, as pharmaceutical costs continue to drive medical impoverishment.

Beyond primary care, India is increasingly prioritizing strategic health autonomy and biosecurity to address global market failures in pharmaceutical R&D. The lack of vaccines for non-Zaire Ebola species highlights the risk of relying on commercial incentives for Neglected Tropical Diseases (NTDs). Consequently, India is strengthening its Biosafety Level 4 (BSL-4) infrastructure and indigenous vaccine R&D (e.g., for Kyasanur Forest Disease). This shift reflects the adoption of a "One Health" framework, recognizing that public health infrastructure must integrate animal-human interfaces to mitigate zoonotic threats and ensure national health security.

The way forward necessitates a policy pivot from an insurance-led model toward a comprehensive Universal Health Care (UHC) framework financed through general taxation. To achieve true health security, India must focus on the following strategic interventions:

Fiscal Scaling: Increasing Government Health Expenditure (GHE) from the current 1.43% to the National Health Policy target of 2.5% of GDP.

Regulatory Oversight: Implementing stringent clinical audits to curb unnecessary medical interventions in the private sector.

Addressing the "Missing Middle": Expanding financial risk protection to those who are neither poor enough for subsidies nor wealthy enough for private insurance.

Infrastructure Integration: Strengthening the synergy between primary health centers and specialized BSL-4 facilities to bridge the gap between routine care and emergency biosecurity.